Wird geladen...
Partnering with PARP inhibitors in acute myeloid leukemia with FLT3-ITD
Internal tandem duplications within the juxtamembrane domain of fms-like tyrosine kinase 3 (FLT3-ITD) occur in acute myeloid leukemia (AML) cells of 20-25% of patients and are associated with poor treatment outcomes. FLT3 inhibitors have been developed, but have had limited clinical efficacy due to...
Gespeichert in:
| Veröffentlicht in: | Cancer Lett |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6528833/ https://ncbi.nlm.nih.gov/pubmed/30953707 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2019.03.048 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|